Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

ADM

This article was originally published in The Tan Sheet

Executive Summary

Ingredient supplier appoints Patricia Schroeder VP-Natural Health & Nutrition Division, reporting to newly-named President Tony DeLio (1"The Tan Sheet" Sept. 24, In Brief). Schroeder, a 26-year veteran of ADM, also will oversee firm's joint venture with KAO, which manufactures and markets diacylglycerol oil, ADM announces Sept. 26. In addition, Michael Baroni and Daniel Larson are named VPs, Specialty Ingredients Division. Baroni will oversee protein business unit while Larson will manage lecithin and monoglyceride operations

You may also be interested in...



ADM

Company restructures food and bioproducts business into three distinct divisions - Natural Health & Nutrition (value-added products), Specialty Ingredients (food) and BioProducts & Feed (feed) -each of which will report to John Rice, senior VP of Food and BioProducts divisions, firm announces Sept. 17. Tony DeLio named president of Natural Health & Nutrition division. DeLio, who joined ADM in 1999, previously headed research and marketing at Mars' Uncle Ben's Rice division

Supplement GMP Warning Letters Make Modest Debut In 2010

Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC

In Brief

Combe sells most of its OTC brands

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS093070

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel